Cargando…
PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
Epstein–Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is an aggressive malignancy that is largely resistant to current therapeutic regimens, and is an attractive target for immune-based therapies. Anti-programmed death-1 (PD-1) antibodies showed encouraging anti-tumor effects in both...
Autores principales: | Quan, Lina, Chen, Xue, Liu, Aichun, Zhang, Yan, Guo, Xiuchen, Yan, Shujie, Liu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567291/ https://www.ncbi.nlm.nih.gov/pubmed/26361042 http://dx.doi.org/10.1371/journal.pone.0136476 |
Ejemplares similares
-
Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023) -
Epstein-Barr Virus-Negative Diffuse Large B-Cell Post-transplant Lymphoma in an Epstein-Barr Virus-Positive Recipient
por: Lee, Charlotte, et al.
Publicado: (2021) -
The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
por: Wang, Lan, et al.
Publicado: (2020) -
A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma
por: Lee, Mi-Hye, et al.
Publicado: (2016) -
Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
por: Wang, Chaoyu, et al.
Publicado: (2021)